• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲的健康声称:以益生菌和益生元为例。

Health claims in Europe: probiotics and prebiotics as case examples.

机构信息

National Institute of Public Health and the Environment, 3720 BA Bilthoven and Maastricht University, 6200 MD Maastricht, the Netherlands.

出版信息

Annu Rev Food Sci Technol. 2012;3:247-61. doi: 10.1146/annurev-food-022811-101206. Epub 2012 Jan 3.

DOI:10.1146/annurev-food-022811-101206
PMID:22224554
Abstract

Health claims regarding foods imply a relationship between a specific food and maintenance of good health, or that food can reduce the risk of disease. Health claim legislation in the European Union sets out from the concept of consumer protection. Health claim assessment focuses on defining given foods, assessing their health relationship, and evaluating relevant studies with an emphasis on controlled human intervention research. Challenges include the focus of claims on healthy populations, although most intervention studies have been conducted among patients. A further problem attends the risk reduction claim, which requires changes in generally accepted biomarkers reflecting the risk of disease. Scientific assessment and guidance documents direct the development of health claims both in Europe and elsewhere. Experience from completed assessments should make it possible to provide consumers with reliable claims to help them make healthier choices and develop lifestyles supporting long-term well-being.

摘要

有关食品的健康声称意味着特定食品与保持良好健康之间的关系,或者食品可以降低疾病的风险。欧盟的健康声称立法基于消费者保护的概念。健康声称评估侧重于定义特定食品,评估它们与健康的关系,并评估相关研究,重点是对照人类干预研究。挑战包括声称针对健康人群,尽管大多数干预研究都是在患者中进行的。另一个问题涉及风险降低的声称,这需要改变反映疾病风险的普遍接受的生物标志物。科学评估和指导文件指导欧洲和其他地区健康声称的制定。已完成评估的经验应使消费者能够获得可靠的声称,以帮助他们做出更健康的选择并形成支持长期健康的生活方式。

相似文献

1
Health claims in Europe: probiotics and prebiotics as case examples.欧洲的健康声称:以益生菌和益生元为例。
Annu Rev Food Sci Technol. 2012;3:247-61. doi: 10.1146/annurev-food-022811-101206. Epub 2012 Jan 3.
2
Functional foods: traditional use and European legislation.功能性食品:传统用途与欧洲法规
Int J Food Sci Nutr. 2012 Mar;63 Suppl 1:7-9. doi: 10.3109/09637486.2011.637488. Epub 2011 Nov 28.
3
The EFSA health claims 'learning experience'.EFSA 健康声称“学习经验”。
Int J Food Sci Nutr. 2012 Mar;63 Suppl 1:14-6. doi: 10.3109/09637486.2011.633899. Epub 2011 Nov 16.
4
Nutraceuticals and botanicals: overview and perspectives.营养保健品和植物药:概述与展望。
Int J Food Sci Nutr. 2012 Mar;63 Suppl 1:2-6. doi: 10.3109/09637486.2011.628012.
5
Probiotics and European Food Safety Authority health claims.益生菌与欧洲食品安全局健康声称
J Clin Gastroenterol. 2010 Sep;44 Suppl 1:S1. doi: 10.1097/MCG.0b013e3181ed7391.
6
A standardised approach towards PROving the efficacy of foods and food constituents for health CLAIMs (PROCLAIM): providing guidance.一种针对食品和食品成分声称健康功效的 PROving(PROCLAIM)的标准化方法:提供指导。
Br J Nutr. 2011 Nov;106 Suppl 2:S16-28. doi: 10.1017/S0007114511003618.
7
Probiotics and prebiotics: health claim substantiation.益生菌与益生元:健康声称的证实
Microb Ecol Health Dis. 2012 Jun 18;23. doi: 10.3402/mehd.v23i0.18568. eCollection 2012.
8
Dose-response relationships in multifunctional food design: assembling the evidence.多功能食品设计中的剂量反应关系:整合证据。
Int J Food Sci Nutr. 2012 Mar;63 Suppl 1:37-42. doi: 10.3109/09637486.2011.636344. Epub 2011 Nov 23.
9
Consumer understanding of nutrition and health claims: sources of evidence.消费者对营养与健康声明的理解:证据来源
Br J Nutr. 2007 Sep;98(3):474-84. doi: 10.1017/S000711450778697X.
10
PASSCLAIM - Synthesis and review of existing processes.PASSCLAIM - 现有流程的综合与审查。
Eur J Nutr. 2003 Mar;42 Suppl 1:I96-111. doi: 10.1007/s00394-003-1105-z.

引用本文的文献

1
Synbiotics: An Emerging Frontier in Infectious Diseases Control.合生元:传染病控制的新兴前沿领域。
Probiotics Antimicrob Proteins. 2025 Aug 13. doi: 10.1007/s12602-025-10690-4.
2
Revisiting the Concepts of Prebiotic and Prebiotic Effect in Light of Scientific and Regulatory Progress-A Consensus Paper From the Global Prebiotic Association.基于科学与监管进展重新审视益生元及益生元效应的概念——全球益生元协会共识文件
Adv Nutr. 2024 Dec;15(12):100329. doi: 10.1016/j.advnut.2024.100329. Epub 2024 Oct 29.
3
Relationship between Oat Consumption, Gut Microbiota Modulation, and Short-Chain Fatty Acid Synthesis: An Integrative Review.
燕麦摄入、肠道微生物群调节与短链脂肪酸合成的关系:综合述评。
Nutrients. 2023 Aug 11;15(16):3534. doi: 10.3390/nu15163534.
4
Probiotics: insights and new opportunities for intervention.益生菌:干预的新视角和新机遇。
Crit Rev Microbiol. 2023 May;49(3):414-434. doi: 10.1080/1040841X.2022.2072705. Epub 2022 May 15.
5
Antimicrobial Potential of the Genera and , as Well as Endolysins Biosynthesized by Their Bacteriophages.[细菌属名]和[细菌属名]的抗菌潜力,以及它们的噬菌体生物合成的内溶素。 (注:原文中两个“Genera”后具体属名缺失)
Antibiotics (Basel). 2022 Feb 12;11(2):242. doi: 10.3390/antibiotics11020242.
6
Clinical Trials of Probiotics in Patients With Irritable Bowel Syndrome: Some Points to Consider.肠易激综合征患者益生菌的临床试验:一些需要考虑的要点。
J Neurogastroenterol Motil. 2022 Apr 30;28(2):204-211. doi: 10.5056/jnm22012.
7
Enterobacter sp. AA26 gut symbiont as a protein source for Mediterranean fruit fly mass-rearing and sterile insect technique applications.肠杆菌属 AA26 肠道共生菌作为地中海实蝇大规模饲养和昆虫不育技术应用的蛋白质来源。
BMC Microbiol. 2019 Dec 24;19(Suppl 1):288. doi: 10.1186/s12866-019-1651-z.
8
Nutraceuticals as modulators of gut microbiota: Role in therapy.营养保健品作为肠道微生物群的调节剂:在治疗中的作用。
Br J Pharmacol. 2020 Mar;177(6):1351-1362. doi: 10.1111/bph.14902. Epub 2020 Jan 3.
9
Cheese Whey Processing: Integrated Biorefinery Concepts and Emerging Food Applications.奶酪乳清加工:综合生物炼制概念与新兴食品应用
Foods. 2019 Aug 15;8(8):347. doi: 10.3390/foods8080347.
10
A Review of Prebiotics Against in Poultry: Current and Future Potential for Microbiome Research Applications.家禽益生元研究综述:微生物组研究应用的现状与未来潜力
Front Vet Sci. 2018 Aug 15;5:191. doi: 10.3389/fvets.2018.00191. eCollection 2018.